2025年10月28日，盘龙药业(002864.SZ)发布2025年第三季报。截至2025年10月27日，共有8个机构投资 者披露持有盘龙药业A股股份，合计持股量达495.38万股，占盘龙药业总股本的4.66%。其中，机构投 资者包括上海浦东发展银行股份有限公司-长信金利趋势混合型证券投资基金、深圳市时代伯乐创业投 资管理有限公司-江西赣江新区财投时代伯乐启辰股权投资中心(有限合伙)、中国工商银行股份有限公 司-融通健康产业灵活配置混合型证券投资基金、深圳市时代伯乐创业投资管理有限公司-时代伯乐定增 10号私募股权投资基金、共青城胜恒投资管理有限公司-胜恒名匠九重风控策略2号私募股权投资基金、 中国建设银行股份有限公司-汇添富中证中药交易型开放式指数证券投资基金、海南墨竹私募基金管理 有限公司-墨竹睡美人三号私募证券投资基金、中国石油天然气集团有限公司企业年金计划-中国工商银 行股份有限公司，机构投资者合计持股比例达4.66%。相较于上一季度，机构持股比例合计上涨了0.93 个百分点。 公募基金方面，本期较上一期持股增加的公募基金共计1个，即汇添富中证中药ETF，持股增加占比达 0.12%。本期较上一季度新披 ...

Core Viewpoint - Zhimin Da (688636.SH) reported a decline in institutional investor holdings in its third-quarter report for 2025, with a total of 17.68 million shares held by five institutional investors, representing 10.55% of the total share capital, a decrease of 7.30 percentage points from the previous quarter [1] Institutional Holdings - As of October 23, 2025, five institutional investors disclosed holdings in Zhimin Da, totaling 17.68 million shares, which is 10.55% of the company's total share capital [1] - The institutional investor group includes notable entities such as Qiongcheng Zhihui Investment Partnership, Bank of China - GF Small and Medium Cap Selected Mixed Securities Investment Fund, and others [1] - The overall institutional holding percentage decreased by 7.30 percentage points compared to the previous quarter [1] Public Fund Holdings - One public fund, Changxin Jinli Trend Mixed A, increased its holdings during this period, with an increase ratio of 0.21% [1] - A total of 254 public funds did not disclose their holdings in this quarter, including funds like GF Technology Innovation Mixed A and others [1]